Cytori’s StemSource® Cell Bank allows patients the opportunity to quickly and efficiently collect and store stem and regenerative cells derived from their own adipose tissue. The StemSource Cell Bank makes the process of preserving the cells cost effective while maintaining their youthful and healthy state. The cells may potentially be utilized in the future to treat a wide variety of medical conditions after approval from the applicable regulatory authorities. The cells are collected in a single procedure, through elective liposuction or as part of an already planned surgery, and can be accessed as desired in the future on multiple occasions.
Cytori commercializes the StemSource® product line to hospitals and companies in Europe, Asia-Pacific, and North America, independently and through partnerships with GE Healthcare and Green Hospital Supply. Green Hospital Supply, an established Japanese healthcare company, is exclusively responsible for commercializing the StemSource Cell Bank in Japan and additional Asian countries. Our strategic cell bank partnership with GE Healthcare covers 12 European countries as well as North America. Cell cryopreservation is estimated to be a large, untapped global medical opportunity.